A man in California filed a lawsuit against manufacturers of Zantac (ranitidine) to pursue justice for the colorectal cancer he developed after regular use of the drug. His case states that the patient ingested 300 mg of ranitidine every day from 2000-2008, and was diagnosed with colorectal cancer in May of 2008.
How is Colorectal Cancer Linked to Zantac?
This lawsuit is one of many asserting that Zantac manufacturers knew/had the responsibility to know about the cancerous risk of the product, but neglected to report this risk publicly or in the medical community. This hazard was exposed when drug testing company Valisure petitioned to recall Zantac in 2019 after finding excessive amounts of the N-nitrosodimethylamine (NDMA) carcinogen in ranitidine samples. Additional research demonstrated that NDMA levels can increase with an increase of temperature, both in storage before the drug is taken and after the patient ingests the medication.
Carcinogens can cause many different types of cancer to form in the body, including colorectal cancer. Colorectal cancer is diagnosed most often in adults over 50-years-old and is the second largest cause of deaths from cancer in the US. Fortunately, it can be caught early through regular screening tests. In addition to using Zantac, colorectal cancer may be caused by a number of things including old age, family history, obesity, heavy alcohol use, and smoking.
How can we help you?
Ranitidine has been consumed nationwide and marketed as a safe product since its release in 1983.Many individuals have been taking Zantac for relief from heartburn, acid reflux, indigestion, and other symptoms for years or maybe even decades. People diagnosed with colorectal cancer after regularly using Zantac deserve justice, and our attorneys at Kwartler Manus, LLC are dedicated to helping them receive the compensation they deserve. In addition to colorectal cancer, the following cancers may qualify for compensation:
Small intestine cancer